Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2 double-blind dose escalation study of KRN5500 for neuropathic pain in patients with cancer.

Trial Profile

A phase 2 double-blind dose escalation study of KRN5500 for neuropathic pain in patients with cancer.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2012

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs KRN 5500 (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2012 Results published in a DARA BioSciences media release
    • 16 Aug 2011 Results accepted for publication by a peer-reviewed medical journal, according to a DARA BioSciences media release.
    • 01 Feb 2011 Results from analyses of this study exploring placebo response will be presented at the International Conference on Accelerating the Development of Enhanced Pain Treatments (ADEPT) to be held in March 2011, as reported in a DARA Biosciences media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top